Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
16
Number of overlapping holdings
26.2%
% of BBP's 65 holdings also in SBIO
18.0%
% of SBIO's 89 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBP |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
ACADIA PHARMACEUTICALS INC | 1.9% | 2.1% | 1.9% | |
KRYSTAL BIOTECH, INC. | 1.7% | 3.4% | 1.7% | |
AGIOS PHARMACEUTICALS INC | 1.5% | 1.6% | 1.5% | |
MIRUM PHARMACEUTICALS, INC. | 2.4% | 1.5% | 1.5% | |
AMICUS THERAPEUTICS INC | 1.4% | 2.0% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to SBIO
ALNYLAM PHARMACEUTICALS INC | 2.1% | |
TRAVERE THERAPEUTICS, INC. | 2.0% | |
LIGAND PHARMACEUTICALS-CL B | 1.9% | |
LEXICON PHARMACEUTICALS, INC. | 1.9% | |
LEGEND BIOTECH CORPORATION SPONSORED | 1.9% | |
IONIS PHARMACEUTICALS, INC. | 1.8% | |
TG THERAPEUTICS INC | 1.8% | |
ADMA BIOLOGICS, INC. | 1.8% | |
INSMED INC | 1.8% | |
GILEAD SCIENCES INC | 1.8% |
BBP Underweight Relative to SBIO
CORCEPT THERAPEUTICS INC | -4.2% | |
ALKERMES PLC | -3.6% | |
ARCELLX, INC. | -3.2% | |
CRINETICS PHARMACEUTICALS INC | -3.1% | |
AVIDITY BIOSCIENCES INC | -2.7% | |
DENALI THERAPEUTICS INC. | -2.3% | |
MERUS N.V. | -2.2% | |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% | |
VERICEL CORPORATION | -2.0% | |
VERA THERAPEUTICS, INC. CLASS A | -1.8% |